Form 4 for NAUT Nautilus Biotechnology, Inc.

Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-05 · accession 0001628280-24-009754 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-03-07	2024-03-05+	NAUT	Patel Sujal M	CEO, Pres, Sec, Dir, 10%	P - Purchase	$2.79	+35.5K	10.03M	+0.4%	+$99.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-03-05	P	A	7,405	$2.65	10,021,893	D	—	—	(F1) Represents the weighted average share price of an aggregate total of 7,405 shares purchased in the price range of $2.58 to $2.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
2	Common	Common Stock	2024-03-07	P	A	18,854	$2.89	10,050,014	D	—	—	(F3) Represents the weighted average share price of an aggregate total of 18,854 shares purchased in the price range of $2.72 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
3	Common	Common Stock	2024-03-06	P	A	9,267	$2.70	10,031,160	D	—	—	(F2) Represents the weighted average share price of an aggregate total of 9,267 shares purchased in the price range of $2.64 to $2.77 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.